Farmington Police Department blotter for May 8, 2021
The Daily Times Staff
Calls for service
This is a digest of service calls performed by the Farmington Police Department. Printed records are available in the department’s lobby at 900 N. Municipal Drive.
• Police responded to a report of an accident with injuries at 1:48 a.m. at the intersection of Resource Avenue and Bloomfield Highway. A report was taken.
• Police responded to a report of a domestic fight at 2:21 a.m. on the 1100 block of Soaring Eagle Drive. A report was taken.
• Police responded to a report of an unwanted subject at 6:14 a.m. on the 500 block of East 15th Street. A report was taken.
Ginkgo agrees to $17.5b merger with Harry Sloanâs SPAC
By Gillian Tan, Crystal Tse and Kristen V. Brown Bloomberg,Updated May 11, 2021, 7:31 a.m.
Email to a Friend
An automated fermenting machine at the Ginkgo Bioworks Inc. facility in Boston.Scott Eisen/Bloomberg
Ginkgo Bioworks Inc., which calls itself an âorganism designâ company, has agreed to go public in a $17.5 billion merger with a blank-check firm backed by former Hollywood executive Harry Sloan.
The Boston-based company, which uses technology to program cells for a potentially wide variety of uses, will combine with Soaring Eagle Acquisition Corp., according to a regulatory filing Tuesday that confirmed an earlier Bloomberg News report.
Ginkgo Bioworks to Become a Public Company and Expand its Leading Platform for Cell Programming
Ginkgo is building the leading horizontal platform for synthetic biology, making it possible to program cells as easily as we can program computers and enabling innovation across industries, including therapeutics, industrials, food and agriculture
News provided by
Share this article
BOSTON and LOS ANGELES, May 11, 2021 /PRNewswire/
Business combination with Soaring Eagle Acquisition Corp. (Nasdaq:SRNG) values Ginkgo Bioworks, Inc. at a $15 billion pre-money equity valuation and is expected to provide up to $2.5 billion of primary proceeds.
Institutional investors have committed $775 million in an oversubscribed PIPE, with anchor investments from Baillie Gifford, Putnam Investments, and funds and accounts managed by Counterpoint Global (Morgan Stanley Investment Management). New investors including accounts advised by ARK Investment Management LLC, ArrowMark Partners, Bain Capital
Synbio Powerhouse Ginkgo Bioworks Goes Public in $17.5B SPAC Deal
May 11, 2021
Synthetic biology powerhouse Ginkgo Bioworks will become a public company through a $17.5 billion merger with a special purpose acquisition company (SPAC) that is expected to provide up to $2.5 billion of gross cash proceeds. [Ginkgo Bioworks]
Share
Synthetic biology powerhouse Ginkgo Bioworks said today it will become a public company through a $17.5 billion merger with a special purpose acquisition company (SPAC) that is expected to provide up to $2.5 billion of gross cash proceeds.
The SPAC business combination with Soaring Eagle Acquisition Corp. implies a pre-money equity valuation of $15 billion for Ginkgo, the company said. Soaring Eagle will change its name to Ginkgo Bioworks Holdings, change its jurisdiction of formation to Delaware and change its ticker symbol from SRNG to a new symbol.
ADVERTISEMENT
ADVERTISEMENT
Ginkgo Bioworks Valued At $15B In SPAC Deal Led By 3 Firms
Law360 (May 11, 2021, 8:44 AM EDT) Ginkgo Bioworks will hit the public markets at a pre-money valuation of $15 billion by merging with a special purpose acquisition vehicle backed by former Metro-Goldwyn-Mayer Studios and CBS executives, the companies said Tuesday, in a deal built by Latham, Wachtell and White & Case.
The agreement sees Boston, Massachusetts-based Ginkgo Bioworks merging with Soaring Eagle Acquisition Corp. and becoming a single, publicly traded entity, according to a statement. As a result of the transaction, Soaring Eagle will change its name to Ginkgo Bioworks Holdings Inc. and its jurisdiction of formation to Delaware. The transaction is co-sponsored by Eagle Equity Partners.